Susquehanna International Group, LLP Ani Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	SELL	$58.53 - $68.82 $70,236 - $82,583	-1,200 Reduced 9.38%	11,600 $738,000
Q1 2024 May 07, 2024	BUY	$54.2 - $69.69 $157,180 - $202,101	2,900 Added 29.29%	12,800 $884,000
Q4 2023 Feb 14, 2024	SELL	$48.72 - $65.43 $199,752 - $268,263	-4,100 Reduced 29.29%	9,900 $545,000
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $221,232 - $284,284	4,400 Added 45.83%	14,000 $812,000
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $29,832 - $43,064	800 Added 9.09%	9,600 $516,000
Q1 2023 May 16, 2023	SELL	$37.61 - $45.72 $372,339 - $452,628	-9,900 Reduced 52.94%	8,800 $349,000
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $28,710 - $37,755	-900 Reduced 4.59%	18,700 $752,000
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $119,320 - $152,040	4,000 Added 25.64%	19,600 $630,000
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $73,888 - $107,072	-3,200 Reduced 17.02%	15,600 $463,000
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $522,054 - $914,710	-19,400 Reduced 50.79%	18,800 $528,000
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $979,209 - $1.69 Million	29,700 Added 349.41%	38,200 $1.76 Million
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $66,200 - $89,975	2,500 Added 41.67%	8,500 $279,000
Q2 2021 Aug 11, 2021	SELL	$31.86 - $38.6 $140,184 - $169,840	-4,400 Reduced 42.31%	6,000 $210,000
Q1 2021 May 17, 2021	SELL	$28.4 - $36.14 $272,640 - $346,944	-9,600 Reduced 48.0%	10,400 $376,000
Q1 2020 May 15, 2020	BUY	$30.35 - $67.14 $78,910 - $174,564	2,600 Added 14.94%	20,000 $815,000
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $127,995 - $183,609	2,300 Added 15.23%	17,400 $1.07 Million
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $951,090 - $1.26 Million	-14,700 Reduced 49.33%	15,100 $1.1 Million
Q2 2019 Aug 14, 2019	BUY	$67.77 - $82.2 $386,289 - $468,540	5,700 Added 23.65%	29,800 $2.45 Million
Q1 2019 May 15, 2019	BUY	$45.83 - $70.54 $563,709 - $867,642	12,300 Added 104.24%	24,100 $1.7 Million
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $193,499 - $265,268	-4,700 Reduced 28.48%	11,800 $531,000
Q3 2018 Nov 14, 2018	SELL	$52.95 - $71.34 $2.45 Million - $3.3 Million	-46,200 Reduced 73.68%	16,500 $933,000
Q2 2018 Aug 14, 2018	SELL	$56.38 - $68.08 $1.22 Million - $1.47 Million	-21,600 Reduced 25.62%	62,700 $4.19 Million
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $2.5 Million - $3.17 Million	43,800 Added 108.15%	84,300 $4.91 Million
Q4 2017 Feb 14, 2018	BUY	$53.3 - $74.56 $1.22 Million - $1.71 Million	22,900 Added 130.11%	40,500 $2.61 Million
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $764,896 - $923,824	17,600	17,600 $924,000

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account